STOP-AMDR

In the Democratic Republic of the Congo, STOP-AMDR is piloting a rotational approach across three health zones. Different artemisinin-based combination therapies are deployed and rotated over two years, while the project examines implementation feasibility, community acceptance, cost, and molecular markers of resistance.







